Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study
{{output}}
Objective: To describe long-term (24-month) treatment patterns of patients initiating galcanezumab versus standard of care (SOC) preventive migraine treatments including anticonvulsants, beta-blockers, antidepressants, and onabot... ...
